- $1.72bn
- $1.98bn
- $632.40m
- 70
- 81
- 80
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 444 | 427 | 424 | 481 | 519 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 437 | 425 | 426 | 458 | 501 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 216 | 103 | 223 | 211 | 177 |
Provision for Income Taxes | |||||
Net Income After Taxes | 168 | 83.7 | 176 | 166 | 145 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 168 | 83.7 | 176 | 166 | 145 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 168 | 83.7 | 176 | 166 | 145 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.88 | 2.99 | 3.23 | 2.99 | 2.79 |
Dividends per Share |